Insider Trading July 2, 2026 03:12 PM

Palmer Square Capital BDC Insider Activity and Market Context

Martin Bicknell's recent share acquisition coincides with analyst revisions and dividend updates for the business development company.

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
PSBD

Martin C. Bicknell, a 10% owner of Palmer Square Capital BDC Inc. (NASDAQ: PSBD), has increased his indirect stake in the company through a series of share purchases totaling $844,800. These transactions, executed on July 1 and July 2, 2026, involved the acquisition of 80,000 shares at prices between $10.55 and $10.57 per share. The purchases were facilitated through MCHC, LLC, an entity controlled by Bicknell. Following these acquisitions, Bicknell's total indirect beneficial ownership includes 311,988 shares via MCHC, LLC, 1,562,896 shares through 1248 Holdings, LLC, and 1,391,817 shares via BFFV, LLC. The article also covers recent corporate actions, including a second-quarter 2026 supplemental dividend of $0.03 per share, an expansion of the share repurchase program by $30 million until June 22, 2027, and analyst updates from RBC Capital and Lucid Capital Markets. Additionally, it notes a 10% reduction in the net asset value of Palmer Square Capital Management's private credit fund in the first quarter, attributed to software asset writedowns.

Palmer Square Capital BDC Insider Activity and Market Context
PSBD
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Martin Bicknell increased his indirect stake in Palmer Square Capital BDC by purchasing 80,000 shares worth $844,800 in early July 2026.
  • The company announced a second-quarter 2026 supplemental dividend and expanded its share repurchase program by $30 million.
  • Analysts from RBC Capital and Lucid Capital Markets have revised price targets and initiated coverage, reflecting mixed views on the company's net asset value and book value recovery potential.

Martin C. Bicknell, identified as a 10% owner of Palmer Square Capital BDC Inc. (NASDAQ: PSBD), has significantly increased his indirect stake in the business development company through a series of strategic share purchases. The transactions, which took place on July 1 and July 2, 2026, involved the acquisition of 80,000 shares of common stock, totaling $844,800 in value. These shares were purchased at prices ranging from $10.55 to $10.57 per share, with 40,000 shares acquired on each of the two days. The purchases were executed indirectly through MCHC, LLC, an entity where Bicknell serves as the sole member and may be deemed to beneficially own the shares. Following these transactions, Bicknell's indirect beneficial ownership in Palmer Square Capital BDC Inc. includes 311,988 shares held by MCHC, LLC, 1,562,896 shares through 1248 Holdings, LLC, which he controls, and 1,391,817 shares through BFFV, LLC, where he serves as the Elected Manager of the entities owning its membership interests.

The stock currently trades at $10.49, slightly below Bicknell's purchase prices, while offering an attractive dividend yield of 15.2%. According to an InvestingPro tip, the company pays a significant dividend to shareholders, though investors should note that InvestingPro's Financial Health score rates the company as "WEAK." InvestingPro offers 3 additional exclusive tips for PSBD subscribers.

In other recent news, Palmer Square Capital BDC announced a second-quarter 2026 supplemental dividend of $0.03 per share, scheduled for payment on July 13, 2026. Additionally, the company expanded its share repurchase program by $30 million, extending it until June 22, 2027, with approximately $22.2 million of shares repurchased to date. RBC Capital revised its price target for Palmer Square Capital BDC to $11.00 from $12.00, maintaining a Sector Perform rating, following a decline in net asset value due to liquid loan pricing and wider spreads. Lucid Capital Markets initiated coverage on the company with a Neutral rating and a price target of $11.50, noting potential for book value recovery despite recent net asset value weakness. In related developments, Palmer Square Capital Management reduced the net asset value of its private credit fund by 10% in the first quarter, attributing the decline to software asset writedowns amid concerns over the impact of artificial intelligence on software business models. These developments highlight ongoing strategic adjustments and market evaluations by Palmer Square Capital BDC and its analysts.

Palmer Square Capital BDC

Follow

Analyze PSBD

Included in our AI-picked strategies

Review strategies

10.37

-0.20

(-1.89%)

Real-time Data

15:30:19

USD

1D

1W

6M

1Y

5Y

Max

Created with Highcharts 11.4.802/07

15:00

16:00

17:00

18:00

19:00

10.3

10.4

10.5

Analyze PSBD

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Is your PSBD trade worth the risk?

Before you click "buy," know exactly where to set your stop-loss. Our Vision AI literally "sees" your PSBD chart and delivers a complete risk management plan—entry, stop-loss, and profit target—in under 60 seconds.

Protect your downside. Validate every trade. Invest smarter.

July Sale - 60% Off InvestingPro

Risks

  • InvestingPro's Financial Health score rates the company as "WEAK," indicating potential financial vulnerabilities.
  • Palmer Square Capital Management reduced the net asset value of its private credit fund by 10% in the first quarter due to software asset writedowns, highlighting concerns over the impact of artificial intelligence on software business models.
  • RBC Capital revised its price target downward following a decline in net asset value due to liquid loan pricing and wider spreads, suggesting market uncertainty.

More from Insider Trading

SentinelOne Chief Executive Executes $1.02 Million Stock Disposition Under Pre-Arranged Plan Jul 2, 2026 Mid Penn Bancorp Director Robert Abel Acquires Additional Shares Amid Strategic Buyback Expansion Jul 2, 2026 Lightbridge Director Sweta Chakraborty Executes Pre-Arranged Stock Sale Amid Nuclear Fuel Development Milestones Jul 2, 2026 Castellum's COO Andrew Merriman Acquires Shares Under ESPP Discount Jul 2, 2026 Agios Pharmaceuticals CMO Divests Shares Amid Clinical and Licensing Developments Jul 2, 2026